Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Silence Therapeutics
Biotech
Pfizer RNA leader runs to Replicate—Chutes & Ladders
Pfizer RNA leader runs to Replicate. Hikma initiates CEO shuffle. Silence says goodbye to CEO.
Darren Incorvaia
,
Zoey Becker
Dec 19, 2025 8:30am
Silence slows zerlasiran, as Hansoh leaves $1.3B biobucks collab
Feb 27, 2025 8:51am
Silence breaks down phase 1 data on blood disorder prospect
Jun 27, 2024 9:40am
Silence loses Mallinckrodt collab, wins in cardiovascular ph. 2
Mar 13, 2024 8:54am
Silence takes back 2 complement programs from Mallinckrodt
Mar 28, 2023 10:42am
Amgen will take heart drug into phase 3 to challenge Novartis
Nov 7, 2022 11:40am
